60.27 USD
↗ 0.57 (0.96%)AT CLOSE (11:59 AM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
63.39
↗ 3.12 (5.18%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
63.39
↗ 3.12 (5.18%)
Market: CLOSED
ELVN is currently priced at $60.28. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ELVN trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 6, 2026.
Open?$59.34
High?$61.86
Low?$59.11
Prev. Close?$59.70
Volume?1.7M
Avg. Volume?1.4M
VWAP?$60.68
Rel. Volume?1.23x
Bid / Ask
Bid?$58.50 × 100
Ask?$67.80 × 100
Spread?$9.30
Midpoint?$63.15
Valuation & Ratios
Market Cap?4.3B
Shares Out?60.9M
Float?45.4M
Float %?76.5%
P/E Ratio?N/A
P/B Ratio?4.76
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
61
Market Cap
4.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
205 PARK ROAD
BURLINGAME, CA 94010
Phone: 650-547-5814
BURLINGAME, CA 94010
Phone: 650-547-5814
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?25
Piotroski F-Score?0/9Weak
Altman Z-Score?169.86Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?19.06%High
Short Interest?8.7M
Days to Cover?9.4
Free Float45.4M
Avg Daily Volume919.3K
Settlement Date2026-07-15
Financial Health
Current Ratio?64.07Strong
Quick Ratio?64.07Strong
Cash Ratio?9.57Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.76FAIR▾
Peers100
S&P38
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-33.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-11.8%WEAK▾
S&P9
ROA?-11.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-67037000
Enterprise Value?$4.1B
Fundamentals ratios updated end of day